Interference by danazol with the Porter-Silber method for determination of urinary 17-hydroxycorticosteroids.
Konishi
H
H
Department of Hospital Pharmacy, Shiga University of Medical Science, Seta, Otsu, Japan. konishi@belle.shiga-med.ac.jp
Minouchi
T
T
Yamaji
A
A
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D002624:Chemistry, Clinical / Q000379:methods; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003350:Cortodoxone / Q000031:analogs & derivatives* / Q000032:analysis; D003613:Danazol / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004965:Estrogen Antagonists / Q000032:analysis; D005189:False Positive Reactions; D006801:Humans; D015203:Reproducibility of Results; D013760:Tetrahydrocortisol / Q000031:analogs & derivatives* / Q000032:analysis; D013761:Tetrahydrocortisone / Q000032:analysis
D015065:17-Hydroxycorticosteroids; D004965:Estrogen Antagonists; C006461:allotetrahydrocortisol; D013761:Tetrahydrocortisone; C009412:tetrahydro-11-deoxycortisol; D013760:Tetrahydrocortisol; D003613:Danazol; D003350:Cortodoxone